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Transient hypophosphatemia is frequently observed during the first months after
renal transplantation and is usually asymptomatic. Phosphate diabetes is defined as
inadequate tubular phosphorus reabsorption leading to persistent renal phosphorus
wasting, which is an important but overlooked cause of osteodystrophy in the post-
renal transplantation population. We report the case of a 58-year-old male who
presented with severe multiple osteoarticular pains within 3 months after successful
first kidney transplantation. Bone disease was attributed initially to mild
hyperparathyroidism secondary to vitamin D deficiency. Despite the correction of
the hyperparathyroidism, the withdrawal of corticosteroids, and the reduction of
immunosuppressive treatment to tacrolimus-based monotherapy, the osteoarticular
pains persisted. Skeletal investigations at month 9 post-transplantation
demonstrated a significant bone mineral density loss associated with osteomalacia
and osteoporosis on the bone biopsy. Laboratory data showed persistent
hypophosphatemia, and phosphate diabetes was then diagnosed explaining the post-
transplant bone disease. A tacrolimus-induced renal tubular disorder was suspected
to contribute to the excessive renal phosphorus wasting. The replacement of
tacrolimus by sirolimus, in addition to oral phosphorus and vitamin D
supplementations, led to the disappearance of pains, the normalization of urinary
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